William John Anderson, M.B.,Ch.B.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Testicular Neoplasms | 8 | 2024 | 799 | 2.200 |
Why?
|
Soft Tissue Neoplasms | 5 | 2023 | 1159 | 1.960 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 3 | 2023 | 77 | 1.660 |
Why?
|
Liposarcoma | 3 | 2024 | 289 | 1.340 |
Why?
|
Sertoli Cell Tumor | 2 | 2023 | 36 | 0.990 |
Why?
|
Leiomyomatosis | 2 | 2022 | 69 | 0.950 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2024 | 64 | 0.910 |
Why?
|
Neoplasms, Connective and Soft Tissue | 1 | 2023 | 34 | 0.830 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 2022 | 20 | 0.810 |
Why?
|
Adenomatoid Tumor | 1 | 2022 | 12 | 0.810 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2022 | 24 | 0.800 |
Why?
|
Antigens, CD34 | 1 | 2024 | 658 | 0.790 |
Why?
|
Uterine Neoplasms | 4 | 2023 | 1420 | 0.760 |
Why?
|
Immunohistochemistry | 13 | 2024 | 11076 | 0.750 |
Why?
|
Pelvic Neoplasms | 1 | 2023 | 247 | 0.740 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2021 | 54 | 0.720 |
Why?
|
Uterine Cervical Diseases | 1 | 2020 | 73 | 0.690 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2023 | 491 | 0.680 |
Why?
|
Sarcoma | 2 | 2023 | 1801 | 0.680 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2022 | 318 | 0.670 |
Why?
|
Vascular Neoplasms | 1 | 2021 | 166 | 0.670 |
Why?
|
Vaginal Diseases | 1 | 2020 | 103 | 0.660 |
Why?
|
Choristoma | 1 | 2020 | 206 | 0.630 |
Why?
|
Gene Fusion | 1 | 2021 | 356 | 0.610 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 3 | 2023 | 118 | 0.550 |
Why?
|
Neuroendocrine Tumors | 1 | 2023 | 641 | 0.540 |
Why?
|
Prostate | 2 | 2022 | 1770 | 0.510 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 368 | 0.470 |
Why?
|
World Health Organization | 1 | 2021 | 1322 | 0.470 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2024 | 2510 | 0.470 |
Why?
|
Kidney Neoplasms | 4 | 2024 | 4249 | 0.440 |
Why?
|
Carcinoma, Renal Cell | 4 | 2024 | 3164 | 0.430 |
Why?
|
Calcinosis | 1 | 2022 | 1469 | 0.430 |
Why?
|
Diagnosis, Differential | 7 | 2024 | 12974 | 0.420 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2016 | 727 | 0.410 |
Why?
|
Seminoma | 2 | 2023 | 134 | 0.380 |
Why?
|
Melanoma-Specific Antigens | 2 | 2021 | 74 | 0.370 |
Why?
|
Bone Neoplasms | 2 | 2021 | 2529 | 0.360 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2016 | 617 | 0.360 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2018 | 1606 | 0.360 |
Why?
|
Repressor Proteins | 1 | 2021 | 2986 | 0.350 |
Why?
|
Skin Neoplasms | 3 | 2024 | 5821 | 0.340 |
Why?
|
Teratoma | 2 | 2024 | 404 | 0.330 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3617 | 0.320 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2016 | 954 | 0.320 |
Why?
|
Epithelial Cells | 1 | 2020 | 3673 | 0.300 |
Why?
|
Fumarate Hydratase | 2 | 2022 | 52 | 0.240 |
Why?
|
Seminal Vesicles | 1 | 2024 | 103 | 0.220 |
Why?
|
Carney Complex | 1 | 2023 | 15 | 0.220 |
Why?
|
Metaplasia | 2 | 2022 | 322 | 0.210 |
Why?
|
Cell Differentiation | 1 | 2020 | 11528 | 0.210 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2022 | 28 | 0.200 |
Why?
|
SOXD Transcription Factors | 1 | 2022 | 44 | 0.200 |
Why?
|
Dyspnea | 2 | 2020 | 1347 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2024 | 368 | 0.190 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2024 | 194 | 0.190 |
Why?
|
Spermatogonia | 1 | 2021 | 30 | 0.190 |
Why?
|
Epithelioid Cells | 1 | 2021 | 60 | 0.180 |
Why?
|
Aged, 80 and over | 6 | 2024 | 58976 | 0.180 |
Why?
|
Young Adult | 8 | 2024 | 59243 | 0.180 |
Why?
|
Smooth Muscle Tumor | 1 | 2020 | 63 | 0.170 |
Why?
|
Adult | 15 | 2024 | 221177 | 0.170 |
Why?
|
Appendix | 1 | 2021 | 109 | 0.170 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2024 | 487 | 0.170 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 245 | 0.160 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2022 | 455 | 0.160 |
Why?
|
Humans | 30 | 2024 | 761504 | 0.160 |
Why?
|
Hypertension, Pulmonary | 2 | 2020 | 1578 | 0.160 |
Why?
|
Male | 18 | 2024 | 360804 | 0.150 |
Why?
|
Aged | 11 | 2024 | 169289 | 0.140 |
Why?
|
Adolescent | 6 | 2024 | 88319 | 0.140 |
Why?
|
Female | 17 | 2024 | 392644 | 0.140 |
Why?
|
Transsexualism | 1 | 2020 | 208 | 0.130 |
Why?
|
Androgens | 2 | 2022 | 1286 | 0.130 |
Why?
|
Chondromatosis, Synovial | 1 | 2016 | 17 | 0.130 |
Why?
|
Middle Aged | 11 | 2024 | 220895 | 0.130 |
Why?
|
Hormone Replacement Therapy | 1 | 2020 | 751 | 0.120 |
Why?
|
History, 21st Century | 1 | 2021 | 1567 | 0.120 |
Why?
|
Biological Products | 1 | 2023 | 914 | 0.120 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 628 | 0.110 |
Why?
|
Actins | 1 | 2021 | 2050 | 0.110 |
Why?
|
Meningioma | 1 | 2022 | 1218 | 0.110 |
Why?
|
Chondrosarcoma | 1 | 2016 | 296 | 0.110 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 1248 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 1 | 2022 | 2803 | 0.100 |
Why?
|
Incidental Findings | 1 | 2016 | 697 | 0.100 |
Why?
|
Carcinoma | 1 | 2022 | 2330 | 0.090 |
Why?
|
Salivary Gland Neoplasms | 1 | 2014 | 304 | 0.090 |
Why?
|
Testosterone | 1 | 2020 | 2472 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4575 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2416 | 0.080 |
Why?
|
Precancerous Conditions | 1 | 2016 | 980 | 0.080 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4111 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2024 | 6346 | 0.070 |
Why?
|
Genetic Testing | 1 | 2018 | 3537 | 0.060 |
Why?
|
Fatal Outcome | 2 | 2020 | 1834 | 0.060 |
Why?
|
Lung | 2 | 2020 | 10000 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5796 | 0.060 |
Why?
|
Cystadenoma, Mucinous | 1 | 2024 | 62 | 0.060 |
Why?
|
Adenoma | 1 | 2014 | 2160 | 0.060 |
Why?
|
Child | 2 | 2022 | 80153 | 0.050 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2023 | 430 | 0.050 |
Why?
|
S100 Proteins | 1 | 2022 | 218 | 0.050 |
Why?
|
Orchiectomy | 1 | 2024 | 463 | 0.050 |
Why?
|
Neurofibromin 2 | 1 | 2022 | 270 | 0.050 |
Why?
|
gp100 Melanoma Antigen | 1 | 2020 | 38 | 0.050 |
Why?
|
MART-1 Antigen | 1 | 2020 | 65 | 0.050 |
Why?
|
Tachycardia, Sinus | 1 | 2020 | 42 | 0.040 |
Why?
|
Receptors, Somatostatin | 1 | 2020 | 136 | 0.040 |
Why?
|
Chromosomes | 1 | 2022 | 577 | 0.040 |
Why?
|
Transcription Factors | 1 | 2018 | 12128 | 0.040 |
Why?
|
Child, Preschool | 1 | 2022 | 42230 | 0.040 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2020 | 273 | 0.040 |
Why?
|
Thrombotic Microangiopathies | 1 | 2020 | 123 | 0.040 |
Why?
|
Mutation | 2 | 2023 | 30052 | 0.040 |
Why?
|
Echocardiography | 2 | 2020 | 4989 | 0.040 |
Why?
|
Vagina | 1 | 2022 | 838 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1745 | 0.030 |
Why?
|
Cough | 1 | 2020 | 594 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13380 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2022 | 2020 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 74206 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 1993 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1552 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2021 | 2909 | 0.030 |
Why?
|
Biopsy | 1 | 2024 | 6766 | 0.020 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2014 | 262 | 0.020 |
Why?
|
Weight Loss | 1 | 2020 | 2684 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5821 | 0.020 |
Why?
|
Electrocardiography | 1 | 2020 | 6377 | 0.020 |
Why?
|
Stroke Volume | 1 | 2020 | 5496 | 0.020 |
Why?
|
Palliative Care | 1 | 2020 | 3598 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9177 | 0.010 |
Why?
|
Heart Failure | 1 | 2020 | 11669 | 0.010 |
Why?
|